This site is a collaboration with the American Society for Clinical Pathology (ASCP)
-
Wanted: An Early Biomarker for Acute Kidney Injury
-
Is It Important to Test for EGFR Mutations in Patients With Lung Cancer?
-
Genetic Ancestry vs Self-Reported Race as a Predictor of Lung Function
-
Detection, Prevention, and Control of MRSA in the NICU
-
Young Women Diagnosed With BRCA Genes -- What Should They Do?
-
CDC Commentary: Testing for Clostridium difficile Infection
-
CDC Commentary: Personal Genomic Testing: Information for Healthcare Providers
-
Neutralizing Antibody to HIV: Exciting New Research
-
Not the Threat You Expect on the Florida Beaches
-
Different Metastasis Pattern Detected in BRCA-Defective Ovarian Cancer
-
Is Mandatory Biopsy in Clinical Trials Justifiable?
-
Demystifying Microsatellite Instability in Stage 2 Colon Cancer
Community Blogs
Commentary and Interviews
POLL
A recent paper in Genome Research identified genetic variants that increase a patient’s susceptibility to chronic pain. How likely or not likely are you to alter a patient’s pain medications proactively if genetic testing suggests the patient might be at increased risk of chronic pain down the road?
Advisory Board
Site Editorial Director
From the American Society for Clinical Pathology
- Increasing Radiation From Sentinel Node Specimens in Pathology Over Time
- E-cadherin Expression in Normal and Abnormal Tissue Specimens From Patients With Pancreatic Carcinoma
- Improved Resolution of Diagnostic Problems in Selected Prostate Needle Biopsy Specimens by Using the ASAP Workup: A Prospective Study of Interval Sections vs New Recut Sections
- Proximal-Type Epithelioid Sarcoma
ASCP Links
Also of Interest
- New Guidelines Issued for Insomnia and Other Sleep Disorders
- Sibutramine Linked to Increased Risk for Nonfatal Vascular Events in Subjects With Preexisting Cardiovascular Conditions